Pink Sheet spoke with Empower General Counsel and Chief Compliance Officer Edgar Gonzalez about the regulatory questions compounders still have heading into the vote On the Peptides for Women podcast, Senior Director, Medical Affairs, Jean Cunningham, PharmD, BCPS, unpacked what patients should know before starting peptide therapy And on the Gladden Longevity podcast, founder and CEO Shaun Noorian talked quality standards and where peptides fit into the future of GLP-1s Swipe through for the highlights
The weekly dosing schedule means each cartridge lasts a long time
BMI Verification: Cross-referencing height and weight data to meet prescribing guidelines
While GLP-1 medications were originally developed for type 2 diabetes, they are now widely used to manage obesity and metabolic syndrome
High TDO expression has been shown to impair T-cell antitumor immunity and to be correlated with poor clinical prognosis
Refrigerate immediately after reconstituting injectable GHK-Cu and use within 28-30 days